Pooled subgroup analysis demonstrates improved glycemic control with tirzepatide in individuals using basal insulin, suggesting enhanced treatment options.
Trials were registered at ClinicalTrials.gov under the identifiers NCT04039503 (SURPASS-5) and NCT04537923 (SURPASS-6).
No takes yet. Share an insight, caveat, or question.
Bajaj et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: